Provider review
Piper (now Polly) review
Flat at every dose, priced per product — and changing its name while you read it.
The flat-price claim is made twice, once site-wide and once on the tirzepatide page, and each product carries its own published rate rather than vanishing into a bundle. The complication is identity: the site announces it is now trading under a different name.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Piper (now Polly)
$135/mo sema · $199/mo tirz, flat at every dose
- Vs median
- $34/mo below the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Same price at every dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
This is close to the cleanest pricing structure here for a low-dose patient. The promise that the monthly figure stays the same at every dose is stated at both the site level and the product level, and because each product carries its own rate on the public page, the claim can be checked per molecule instead of taken on faith. There is no membership charge and no separate visit fee, shipping is free and next-day, and the plans are FSA and HSA eligible. Two cautions. The first is the rebrand — the site says it is now Polly while the domain and most third-party listings still say Piper, so anyone researching reviews may not be reading about the entity they are buying from, and that is worth confirming before you hand over a card. The second is the usual one: no pharmacy is named. Neither undoes the pricing, which is genuinely good.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want a flat rate that does not move with your dose, stated plainly and in more than one place.
- You want each product priced on its own rather than bundled into a single opaque plan.
- You are paying with an FSA or HSA card.
Look elsewhere if
- You want certainty about who you are buying from. The brand is mid-rename.
- You want the compounding pharmacy named before you order.
- You want the billing cycle spelled out on the same card as the price; the cards label the injection cadence instead.
What it actually costs
Price as published
Compounded semaglutide $135 · compounded tirzepatide $199 · sermorelin $179 · lipotropic (MIC) + B12 $99 · NAD+ spray $199 · sold with "Same price for every dose" and "Your monthly price stays the same at every dose, with no surprise increases" · no membership fee, FSA and HSA eligible, free next-day shipping · the site is mid-rebrand — its own banner reads "Piper is now Polly, same care", and the FAQ answers "What is Polly?" rather than what Piper is
- Vs median
- $34/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Same price at every dose
One figure regardless of how much drug you take. Reassuring if you expect to titrate upward, and the least economical structure on this page if you do not: a quarter dose costs what a full one does.
88 of the 373 programs we track price a small dose this way. The flat-at-every-dose promise is made at both the site level and the product level, and each molecule carries its own published rate rather than disappearing into one bundled plan — so the claim can be checked per product instead of taken on trust. For a low-dose patient the consequence is the same as any flat plan: the dose is free to choose because it changes nothing about the bill, which makes the decision clinical rather than financial.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Flat at every dose
- Price last updated
- August 2026
What it does well
- Flat pricing at every dose, stated twice in the provider's own words — "Same price for every dose" on the homepage and "Your monthly price stays the same at every dose, with no surprise increases" on the tirzepatide page
- Every product carries its own published price on the public page, so nothing has to be extracted from an intake funnel
- No membership fee and no separate consultation charge layered onto the medication price
- FSA and HSA eligible, with free next-day shipping stated on the same card as the price
- Sells more than the two GLP-1s — sermorelin, a lipotropic B12 injection and an NAD+ spray each carry a separate published rate rather than being bundled invisibly
Pharmacy, labs and oversight
Piper (now Polly) dispenses through a Not named — "a licensed partner pharmacy" facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
4 of 4 published openly
What Piper (now Polly) publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsOne price at every dose, so the bill is knowable before you titrate.
- Published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Piper — renaming itself Polly at the time of writing — is a telehealth platform connecting patients to independent licensed clinicians and mail-order pharmacies, selling compounded semaglutide and tirzepatide alongside sermorelin, a lipotropic B12 injection and an NAD+ spray. Each product carries its own published price on the homepage rather than a single bundled plan, and the pricing promise is explicit at both the site and product level: the monthly figure does not change as the dose rises. There is no membership charge and no separate visit fee, shipping is free and next-day, and the plans are FSA and HSA eligible. Prescriptions ship from a licensed partner pharmacy that the site does not name.
The honest cons
The brand is changing names mid-flight. The site announces "Piper is now Polly" while the domain, its directory listings elsewhere and much of the copy still say Piper, so a patient checking reviews may not be reading about the same entity they are buying from
- No pharmacy is named — prescriptions ship from "a licensed partner pharmacy" with no identity given
- The product cards label the injection frequency rather than the billing cycle, so the price and the cadence sit side by side without either being defined against the other on the card itself
- No LegitScript seal is displayed
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Piper (now Polly) is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#162 of 373
Ordered with the companies that pay us first, and Piper (now Polly) is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- What a flat price costs at a low dose
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
MadeMed
$239/mo flat
- Vs median
- $70/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Same price at every dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the MadeMed review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.